News in brief: Fevertree Drinks, Lakehouse, Gateley, Non-Standard Finance, ImmuPharma, Osirium Technologies
Fevertree goes for the doubleAnalysts have once again upgraded earnings forecasts for Fevertree Drinks (FEVR) following another bullish trading update. Investec lifts its 2016 pre-tax profit estimate by 9% to £26.5 million. That is...
28 July 2016